• American Joint Committee on Cancer

Summary of Changes

The definition of TNM and the Stage Grouping for this chapter have not changed from the Fifth Edition.


Spermatic Cord Serum Tumor Marker Tunica Albuginea Granulosa Cell Tumor Germ Cell Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bajorin D, Katz A, Chan E, et al: Comparison of criteria for assigning germ cell tumor patients to “good risk” and “poor risk” studies. J Clin Oncol 4:786–792, 1986Google Scholar
  2. Birch R, Williams S, Cone A, et al: Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 4:400–407, 1986PubMedGoogle Scholar
  3. Boyer M, Raghavan D: Toxicity of treatment of germ cell tumors. Semin Oncol 19:128–142, 1992PubMedGoogle Scholar
  4. Einhorn LH: Testicular cancer as a model for a curable neoplasm: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res., 41:3274–3280, 1981Google Scholar
  5. Freedman LS, Parkinson MC, Jones WG, et al: Histopathology in the prediction of relapse of patients with Stage I testicular teratoma treated by orchiectomy alone. Lancet 2:294–298, 1987PubMedCrossRefGoogle Scholar
  6. Hoskin P, Dilly S, Easton D, et al: Prognostic factors in Stage I non-seminomatous germ cell tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 4:1031–1036, 1986PubMedGoogle Scholar
  7. International Germ Cell Cancer Collaborative Group: International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594–603, 1997Google Scholar
  8. Mead GM, Stenning SP, Parkinson MC, et al: The Second Medical Research Council study of prognostic factors in non-seminomatous germ cell tumors. J Clin Oncol 10:85–94, 1992PubMedGoogle Scholar
  9. Peckham MJ, Barrett A, McElwain TJ et al: Nonseminoma germ cell tumours (malignant teratoma) of the testis: results of treatment and an analysis of prognostic factors. Br J Urol 53:162–172, 1981PubMedCrossRefGoogle Scholar
  10. Raghavan D, Colls B, Levi J, et al: Surveillance for Stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been defined. Br J Urol 61:522–526, 1988PubMedCrossRefGoogle Scholar
  11. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etposide. N Engl J Med 317:1433–1438, 1987PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • American Joint Committee on Cancer
    • 1
  1. 1.Executive OfficeChicagoUSA

Personalised recommendations